| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/10/2007 | CA2627912A1 Treatment of diabetes |
| 05/09/2007 | EP1782810A2 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 05/09/2007 | EP1781598A1 Androgen modulators |
| 05/09/2007 | EP1781280A2 Androgen modulators |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | CN1960980A Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (VMS) |
| 05/09/2007 | CN1960742A Drug for ameliorating male climacteric disorder |
| 05/09/2007 | CN1960739A Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
| 05/09/2007 | CN1960735A Use of drug combinations for treating insulin resistance |
| 05/09/2007 | CN1957948A Modified montmorillonite, preparation method and application |
| 05/09/2007 | CN1314701C New etonogestrel esters |
| 05/09/2007 | CN1314406C Application of montmorillonite in pharmacy |
| 05/08/2007 | US7214706 Osteoporosis, postmenopause |
| 05/08/2007 | US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/03/2007 | WO2007050726A2 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 05/03/2007 | WO2007050723A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007049798A1 Novel benzoxathiin derivative |
| 05/03/2007 | WO2006108667A3 Method of treatment using gh antagonist and somatostatin agonist |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070098808 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| 05/03/2007 | US20070098757 E-PTFE foil impregnated with an encapsulated bioactive substance |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | CA2627653A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/03/2007 | CA2627139A1 Novel benzoxathiin derivative |
| 05/02/2007 | EP1779851A1 Treatment of diabetes |
| 05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 05/02/2007 | EP1778253A1 Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors |
| 05/02/2007 | EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
| 05/02/2007 | EP1778222A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1311248B1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP0869968B1 Growth-hormone secretagogues |
| 05/02/2007 | CN1956954A Novel androgens |
| 05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 05/02/2007 | CN1313494C Fusion protein possessing growth facilitation action and its coding gene and uses |
| 05/02/2007 | CN1313439C Compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313095C Starter kit for low dose oral contraceptives |
| 05/02/2007 | CN1313082C Slow releasing composition and its preparing method |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211604 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | CA2366679C Stabilized oral pharmaceutical composition containing iodide and iodate and method |
| 05/01/2007 | CA2305458C Nonsteroidal (hetero) cyclically-substituted acylanilides with mixed gestagenic and androgenic activity |
| 04/26/2007 | US20070093411 Diabetic inhalant formulation including surfactant and optionally preservative, isotonicizing agent, buffer and/or excipient |
| 04/26/2007 | US20070092551 Therapeutic agent |
| 04/25/2007 | EP1777231A2 Process of purication of LH and recominant hLH purified by that method |
| 04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
| 04/25/2007 | EP1776137A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 04/25/2007 | EP1776107A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1197208B1 Sustained release compositions, process for producing the same and use thereof |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953756A Insulin resistance improving agent |
| 04/25/2007 | CN1951965A Glp－1衍生物 Glp-1 derivatives |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/24/2007 | US7208594 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
| 04/24/2007 | US7208522 Methods and compositions for the prevention and treatment of Syndrome X |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208283 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2340343C Enantioselective synthesis |
| 04/24/2007 | CA2307820C Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
| 04/24/2007 | CA2138451C Sugar-coated pharmaceutical dosage unit |
| 04/19/2007 | WO2007044560A2 Modulators of atp-binding cassette transporters |
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043365A1 Therapeutic agent for neurogenic pain |
| 04/19/2007 | WO2007041833A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 04/19/2007 | WO2007025632A3 Nitrooxy derivatives op glucocorticoids |
| 04/19/2007 | WO2007020013A3 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 04/19/2007 | WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof |
| 04/19/2007 | WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof |
| 04/19/2007 | WO2006131799A3 Compositions based on phyto-oestrogen extracts for the treatment of menopausal and pre-menstrual syndrome, benign prostate hypertrophy, and polycystic ovary syndrome |
| 04/19/2007 | WO2005120466A3 Sugar coatings and methods therefor |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | CA2625150A1 Combined use of dpp-iv inhibitors and gastrin compounds |
| 04/19/2007 | CA2624683A1 Modulators of atp-binding cassette transporters |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1773816A2 Modulators of atp-binding cassette transporters |
| 04/18/2007 | EP1773813A1 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 04/18/2007 | EP1773780A2 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773750A1 Chemical compounds |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1187846B1 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |